A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy

Recruiting · NCT06754488 · Interventional (participants receive a specific treatment) · Lead sponsor: Suzhou Municipal Hospital

View the official record on ClinicalTrials.gov →

Prostate cancer

Interventions studied

Posterior Reconstructionanterior suspension

What this trial is about

Laparoscopic radical prostatectomy (LRP) is the main treatment method for early prostate cancer, and postoperative urinary incontinence is one of the main complications after LRP. Urologists have applied various new operations in clinical practice to improve the urinary incontinence of patients after LRP surgery, but urinary incontinence is still the main problem affecting the quality of life of patients after surgery. In recent years, we have found that the new bladder neck urethral reconstruction method adopted by our department in LRP surgery can effectively improve the postoperative urinary incontinence of patients. In this study, a randomized controlled trial was intended to verify that the new bladder and neck urethral reconstruction technique could effectively improve early urinary control in patients after radical laparoscopic prostatectomy, and the patients were randomly divided into four groups by factorial design: posterior reconstruction group, posterior reconstruction +anterior suspension group, Sham group, and anterior suspension group to further verify the influencing factors of improved urinary control. The aim is to prove that the new operation can effectively reduce the urinary incontinence rate of patients after LRP, and analyze the mechanism of the new operation to improve the urinary incontinence of patients after LRP, and provide a new idea for the reconstruction of bladder neck and urethra during laparoscopic radical prostatectomy.

Who can take part

Age range

Up to 79 Years

Sex

Male

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not applicable (e.g. observational or device study)

Study type

Interventional (participants receive a specific treatment)

Inclusion criteria

Preoperative needle biopsy confirmed prostate cancer; (2) The clinical stage is T1 and T2

Exclusion criteria

Diseases that significantly increase the risk of surgery or anesthesia, such as severe cardiovascular diseases, respiratory diseases, and coagulation disorders. (2) Patients with extensive bone metastasis or metastases to other organs (3) patients with a history of urinary incontinence and transurethral resection of the prostate. (4) Tumor invasion of bladder neck.

Where it is running

1 location listed.

Suzhou Municipal Hospital - Suzhou, Jiangsu, China

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →